Loading

Legalization

  • by Paul Armentano, NORML Deputy Director July 11, 2018

    The enactment of medical cannabis access laws is associated with significant reductions in prescription opioid use among Medicaid enrollees, according to just-published data in the journal Addiction.

    Investigators with the University of California at San Diego assessed the relationship between medical cannabis legalization and opioid use among Medicaid enrollees over a period of 21 years (1993 to 2014).

    Authors reported, “For Schedule III opioid prescriptions, medical cannabis legalization was associated with a 29.6 percent reduction in number of prescriptions, 29.9 percent reduction in dosage, and 28.8 percent reduction in related Medicaid spending.” This correlation remained after authors controlled for potential confounders, such as the establishment of prescription drug monitoring programs and variations in patients’ income.

    By contrast, authors did not report similar changes in enrollees’ use of Schedule II opioid drugs, like Oxycodone. Authors speculated that this result may be because physicians are more reticent to recommend medical cannabis options to these patients.

    They concluded: “In this study, we found that statewide medical cannabis legalization implemented in 1993-2014 in the US was associated with close to 30 percent reductions in Schedule III opioids received by Medicaid enrollees.. … It was estimated that, if all the states had legalized medical cannabis by 2014, Medicaid annual spending on opioid prescriptions would be reduced by 17.8 million dollars.”

    Their findings are similar to those of numerous other observational studies – such as those here, here, and here – finding that medical marijuana regulation is correlated with reductions in overall opioid-related use, drug spending, abuse, hospitalization, and mortality. Separate data evaluating prescription drug use trends among individual patients enrolled in state-licensed medical marijuana programs is consistent with this conclusion, finding that many subjects reduce or eliminate their use of opioids following enrollment.

    The abstract of the new study, “Medical cannabis legalization and opioid prescriptions: Evidence of US Medicaid enrollees during 1993-2014,” appears online here.

  • by Paul Armentano, NORML Deputy Director July 9, 2018

    Legalize marijuanaProponents of a statewide ballot initiative to legalize the adult use of marijuana in North Dakota turned in nearly 19,000 signatures to the Secretary of State’s office today in an effort to place the measure before voters this November. State officials must certify 13,452 signatures in order to qualify the measure for the 2018 electoral ballot.

    The voter-initiated measure, organized by the grass-roots group Legalize North Dakota, legalizes the possession, use, and sale of cannabis, as well as the possession of marijuana paraphernalia, by those over the age of 21 and also expunges past marijuana convictions.

    In 2016, nearly two-thirds of state voters approved a ballot measure regulating medical cannabis access. However, state officials have yet to make the program operational — with regulators now aiming to have licensed dispensaries up and running by June 2019. Regulators’ failure to swiftly implement the 2016 measure was the impetus for the 2018 campaign, activists have acknowledged.

    State officials are anticipated to take an estimated 35 days to verify proponents’ signatures. According to internal polling data commissioned by the Legalize North Dakota campaign, a plurality of voters back the measure.

    Voters in Michigan will also be deciding this November on whether to legalize the adult use of marijuana, while voters in Utah and Missouri will be deciding on medical access measures.

  • by NORML June 29, 2018

    Vermont Legalizes MarijuanaAdults in Vermont will be able to possess and grow personal use quantities of cannabis legally under state law, beginning this Sunday, July 1.

    Vermont joins Alaska, California, Colorado, the District of Columbia, Maine, Massachusetts, Nevada, Oregon, and Washington in legalizing the adult possession and use of marijuana. It is the first state to enact legalization via an act of the legislature rather than by the passage of a voter initiative.

    “The majority of Vermonters, like the majority of the American public, desire to live in a community where responsible adults who choose to consume cannabis are no longer criminalized or stigmatized,” NORML Deputy Director Paul Armentano said. “Vermont lawmakers and Gov. Scott are to be recognized for responding to the will of the voters, rather than choosing to ignore them.”

    He added: “Vermont is leading by example. Lawmakers in other states would be wise to follow.”

    The new law, which Republican Gov. Phil Scott signed in January, legalizes activities by adults specific to the possession of up to one ounce of cannabis, and with regard to the private cultivation of six marijuana plants (two mature and up to four immature). Those who cultivate marijuana for their own personal use may possess at home the total quantity of their harvest. The measure also imposes new civil penalties for consuming cannabis while driving, and imposes additional penalties for those who operate a motor vehicle impaired with a minor in the vehicle. (Read a summary of the new law here.)

    “This is a libertarian approach,” Gov. Scott said prior to signing the bill into law. “I know there are diverse opinions … as to whether we should move forward, but I still firmly believe that what you do in your own home should be your business, as long as it doesn’t affect someone else.”

    Over 20 percent of the US population now resides in jurisdictions where adult marijuana use is legal under state law. To date, the enactment of these policies has not been associated with any significant upticks in either crime, adolescent marijuana use, or motor vehicle accidents. Earlier this month, Canada’s Parliament passed legislation legalizing the use, cultivation, and retail sale of marijuana by those age 18 and older. That new law takes effect on October 17, 2018.

    According to nationwide polling data published last week, 68 percent of US voters – including majorities of Democrats, Republicans, and Independents – support legalizing and regulating the use of marijuana by adults. That percentage is the highest level of support ever reported in a nationwide scientific poll.

  • by Paul Armentano, NORML Deputy Director June 19, 2018

    [UPDATE: Prime Minister Justin Trudeau has announced that the new law will officially go into effect on October 17, 2018.]

    Members of the Canadian House and Senate have reconciled and given final approval to C-45, sweeping legislation amending the federal Controlled Drugs and Substances Act so that those over the age of 18 may legally possess, purchase, and grow personal use quantities of cannabis.

    Majorities of both chambers had previously approved slightly different versions of the measure. Today, Senate lawmakers voted 52-29 to concur with the House’s final version of the bill. According to the BBC, “the bill will likely receive Royal Assent this week, and the government will then choose an official date when the law will come into force.” The new law is anticipated to take effect by mid-September, at which time licensed cannabis retailers are expected to be operational.

    The Act permits those age 18 and older to legally possess and purchase personal use amounts of marijuana or marijuana-infused products from licensed sellers. Households will also be permitted to grow up to four cannabis plants for personal use. Commercial marijuana production will be licensed by the federal government, while retail distribution of marijuana will be regulated by individual provinces. A Senate amendment that sought to allow provinces to limit or prohibit personal cultivation was ultimately rejected by members of the House. The new law will not amend Canada’s existing medical cannabis access regulations, which permit registered patients to grow or purchase cannabis from authorized licensed producers.

    NORML Executive Director Erik Altieri praised the vote. “We applaud Canada for showing federal legislators in the United States what can be accomplished with true leadership and dedication to sound public policy,” he said. “America’s leaders would be wise to learn from our neighbors, and similarly replace our archaic and failed marijuana prohibition laws with a regulatory scheme that is largely evidence-based and that reflects cannabis rapidly changing cultural status.”

  • by NORML

    Congresswoman Eleanor Holmes Norton (D-DC) has introduced legislation to protect state-lawful marijuana users from housing discrimination.

    Entitled the “Marijuana in Federally Assisted Housing Parity Act of 2018,”  the legislation includes protections for consumers in both medical and adult use states. It states, “A public housing agency or an owner of federally assisted housing may not establish standards prohibiting admission to the program or federally assisted housing to any household with a member who engages in the use, distribution, possession, or cultivation of marihuana… in compliance with the law of the State in which such use, distribution, possession, or cultivation takes place.”

    Under the current federal policy, those who consume any controlled substance defined as illegal under federal law, including medical marijuana, are prohibited from being admitted to federally assisted housing. Federal law also allows landlords to evict current residents based on their use of marijuana for any purposes, including the use of medical cannabis by state-qualified patients.

    You can contact your Representative and urge their support for this measure by clicking here. 

     

Page 1 of 6512345...102030...Last »